Go Pro
NASDAQ:MLEC

Moolec Science (MLEC) Stock Price, News & Analysis

Moolec Science logo
$5.85 -0.41 (-6.55%)
Closing price 03:56 PM Eastern
Extended Trading
$5.74 -0.11 (-1.79%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Moolec Science Stock (NASDAQ:MLEC)

Advanced

Key Stats

Today's Range
$5.50
▼
$6.36
50-Day Range
$5.50
▼
$8.57
52-Week Range
$3.08
▼
$23.22
Volume
20,642 shs
Average Volume
22,887 shs
Market Capitalization
$4.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Moolec Science S.A. is an agricultural biotechnology company developing foods and ingredients through molecular farming, a technology that uses plants to produce targeted proteins and other biological compounds. The company’s approach is intended to support the development of more sustainable and scalable alternatives for the food and agriculture industries.

Moolec’s research focuses on producing animal proteins in crops, including soybeans and safflower. Its best-known program, “Piggy Sooy,” uses genetically engineered soybeans designed to produce porcine proteins within the seed, with the goal of creating plant-based ingredients that more closely replicate the taste, texture and nutritional characteristics of animal-derived products. The company has also described additional applications for molecular farming across food and ingredient markets.

Moolec was founded by scientists and entrepreneurs with backgrounds in biotechnology, food production and agriculture. Gastón Paladini serves as chief executive officer and is associated with the Paladini food business in Argentina, while the company’s scientific leadership includes co-founder and chief technology officer Martin Salinas. Moolec has conducted research and development activities in the United States and South America and is listed on the Nasdaq under the symbol MLEC.

AI Generated. May Contain Errors.

Moolec Science Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

MLEC MarketRank™: 

Moolec Science scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Moolec Science.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Moolec Science is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Moolec Science is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

    1.53% of the float of Moolec Science has been sold short.
  • Short Interest Ratio / Days to Cover

    Moolec Science has a short interest ratio ("days to cover") of 0.25, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Moolec Science has recently increased by 475.79%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Moolec Science does not currently pay a dividend.

  • Dividend Growth

    Moolec Science does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Moolec Science this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Moolec Science insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    0.07% of the stock of Moolec Science is held by institutions.

  • Read more about Moolec Science's insider trading history.
Receive MLEC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MLEC Stock News Headlines

MLEC Share News Today
Bezos… DOOMED
A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X combined - aimed at the $25 trillion AI industry. James Altucher says the plan could cut Amazon out of the AI race and disrupt Blue Origin, with a key deadline landing September 25.tc pixel
See More Headlines

MLEC Stock Analysis - Frequently Asked Questions

Moolec Science's stock was trading at $3.8190 at the beginning of the year. Since then, MLEC shares have increased by 53.2% and is now trading at $5.85.

Moolec Science SA (NASDAQ:MLEC) announced its quarterly earnings results on Wednesday, April, 16th. The company reported ($9.00) earnings per share for the quarter, meeting analysts' consensus estimates of ($9.00). The company earned $2.64 million during the quarter, compared to the consensus estimate of $2.01 million.

Moolec Science shares reverse split on Monday, January 5th 2026.The 1-15 reverse split was announced on Wednesday, December 31st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Moolec Science investors own include PayPal (PYPL), TriNet Group (TNET), Tesla (TSLA), ABM Industries (ABM), Adverum Biotechnologies (ADVM), APi Group (APG) and Avino Silver & Gold Mines (ASM).

Company Calendar

Last Earnings
4/16/2025
Today
9/24/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Food Products
Sub-Industry
Agricultural Products & Services
Current Symbol
NASDAQ:MLEC
CIK
1937737
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.79
Current Ratio
0.15
Quick Ratio
0.08

Sales & Book Value

Annual Sales
$333.61 million
Price / Sales
0.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($309.64) per share
Price / Book
-0.02

Miscellaneous

Outstanding Shares
730,000
Free Float
582,000
Market Cap
$4.27 million
Optionable
Not Optionable
Beta
0.26
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:MLEC) was last updated on 9/24/2026 by MarketBeat.com Staff.
From Our Partners